SPRR1A and myocardial infarction: Given our results that proapoptotic Sprr1a is a direct and functional target for CM miR-150 (Figure 4, Figure 5, and Figure 8), MI patients with decreased levels of miR-150 could be, in particular, considered for future targeted treatments based on Sprr1a.